Academic Journals Database
Disseminating quality controlled scientific knowledge

DEVELOPMENT AND VALIDATION OF RP-HPLC AND SPECTROPHOTOMETRIC METHOD FOR SIMULTANEOUS ESTIMATION OF ATORVASTATIN AND AMLODIPINE IN PHARMACEUTICAL DOSAGE FORMS

ADD TO MY LIST
 
Author(s): Amit Kumar Sharma* and Abhay Dharamsi

Journal: International Journal of Pharmaceutical Sciences and Research
ISSN 0975-8232

Volume: 3;
Issue: 4;
Start page: 1202;
Date: 2012;
VIEW PDF   PDF DOWNLOAD PDF   Download PDF Original page

Keywords: Atorvastatin (ATR) | Amlodipine (AML) and Diclofenac | RP-HPLC | C18 (4.6*250) mm | 5 micron column | Validation

ABSTRACT
A simple, rapid, precise, accurate, sensitive and time consuming reverse phase high performance liquid chromatography (RP-HPLC) and spectrophotometric method for simultaneous estimation of atorvastatin and amlodipine in pharmaceutical dosage forms have been developed and validated. Drug was resolved on a C18 column (Phenomenex phenyl hexyl column, 250mm* 4.6mm i.d, 5um). Utilizing mobile phase of water with 0.4%v/v triethyl amine and acetonitrile with diluted orthophosphoric acid pH adjusted to 5.2 in a ratio of 52.5:47.5 of water and acetonitrile respectively. Mobile phase was delivered at the flow rate of 1.0ml/min. Ultraviolet detection was carried out at 229nm. Separation was completed within 7.75 minutes. Calibration curve was linear with correlation coefficient (r2) =0.999. Over a concentration range 5-25ug/ml, using diclofenac 10ug/ml as IS. Recovery was between 99.26, 100.2 percentage. In spectrophotometric method it involves the formation and solvation of simultaneous equation at 242nm for Atorvastatin and 256nmfor Amlodipine using Acetonitrile and Water (10:90) as mobile phase. The standard deviation was found to be less than 1% for the assay of tablet. The proposed methods were successfully employed for the estimation of Atorvastatin and Amlodipine in combined tablet formulation.
Affiliate Program     

Tango Rapperswil
Tango Rapperswil